Regenxbio RGNX Cash Flow Statement (2014-2026)

NASDAQ RGNX
$7.40 +0.25 (+3.50%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Regenxbio Quarterly Cash Flow Statement

Periods 47 quarters
Latest Jun 2026

Regenxbio cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 47 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-57.64M-58.41M294.02M-76.72M-68.18M-75.48M-59.94M-66.68M-72.06M-61.87M-62.89M-63.33M-52.99M-59.60M-51.19M6.08M-70.87M-61.94M-67.15M22.69M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
2.20M2.83M2.64M2.59M2.64M3.55M4.13M4.18M4.44M4.37M4.34M4.18M4.05M3.96M4.02M3.96M3.91M3.89M3.87M
Share-based CompensationStock Comp.
9.99M9.73M9.16M10.80M10.34M10.25M9.41M11.21M10.50M10.22M8.34M9.60M9.44M9.88M9.54M8.54M8.65M9.00M8.38M9.05M
Gains from Investment SecuritiesGains Investment
5.18M-0.01M
Asset Writedowns and ImpairmentWritedown
2.10M
Other non-cash itemsOther Non-Cash
-0.10M0.62M0.24M-0.08M1.02M0.11M-0.68M-0.70M-0.71M0.83M0.48M0.62M-0.72M0.45M7.07M-0.29M2.79M5.35M5.64M
Change in Working Capital
Change in ReceivablesChange Receivables
3.10M6.40M-22.00M-5.69M10.72M-5.01M-4.84M-9.50M2.39M6.54M-3.37M-9.18M6.89M0.71M-8.13M-1.57M2.36M6.31M0.56M
Change in Account PayablesChange Payables
-1.13M7.35M-8.81M16.76M-7.23M7.36M1.91M-3.10M-11.01M10.10M1.22M8.46M-14.92M3.12M3.04M-3.65M2.53M0.69M-1.86M
Change in Accured ExpensesChange Accured Exp.
4.66M6.35M29.44M-26.47M0.88M-2.65M2.63M-15.44M18.94M-5.05M4.00M-17.08M9.53M6.10M-10.68M-14.49M11.92M2.75M0.05M
Change in Other Operating AssetsOther Assets Change
-1.14M6.20M1.14M-2.13M-4.35M-1.36M-1.74M15.78M-7.09M-2.43M-2.45M3.78M-10.18M0.63M-13.19M1.62M0.26M2.87M-8.58M
Change in Other Operating LiabilitiesOther Liabilities Change
6.31M0.33M0.62M7.94M3.86M-1.08M-4.32M-4.79M-2.51M-1.56M-1.81M-4.94M-1.93M-1.82M-2.03M34.60M-4.30M-4.64M-8.00M
Other Working Capital ChangesOther WC Changes
7.45M-5.87M-0.53M10.07M8.21M0.27M-2.58M-20.56M4.57M0.87M0.64M-8.72M8.25M-2.45M11.16M32.98M-4.56M-7.51M0.58M
Cash from OperationsCash from Ops.
-36.07M-42.50M341.50M-55.91M-61.75M-50.46M-39.37M-80.92M-47.32M-49.41M-40.76M-55.46M-45.50M-40.55M-31.62M33.63M-49.34M-55.96M-52.29M
Investing Activities
Capital ExpendituresCapex
19.84M18.70M14.61M10.97M9.24M5.05M5.47M4.82M2.58M1.44M1.13M0.56M0.47M0.33M1.08M1.02M0.39M0.49M0.51M
Change in Property, Plant and EquipmentChange in PP&E
-19.84M-18.70M-14.61M-10.97M-9.24M-5.05M-5.47M-4.82M-2.58M-1.44M-1.13M-0.56M-0.47M-0.33M-1.08M-1.02M-0.39M-0.49M-0.51M
Purchase of InvestmentsInvestments Purchased
8.36M20.68M235.47M129.49M28.87M14.55M11.97M49.80M18.13M18.64M55.19M82.53M36.20M16.22M19.16M211.14M39.52M62.81M
Sale and Maturity of InvestmentsInvestments Sold
36.01M49.92M33.73M49.86M37.03M72.12M44.14M67.91M107.59M56.25M53.74M68.93M82.73M86.78M51.79M64.92M71.10M82.24M100.86M
Cash from Investing ActivitiesCash from Investing
7.80M16.10M-216.36M-90.59M-1.08M53.04M26.70M63.09M55.22M38.66M33.97M13.18M-0.27M50.26M40.27M44.74M-140.44M42.29M37.54M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.28M2.87M1.00M0.96M1.51M2.04M0.04M1.05M0.75M6.21M0.21M132.90M-0.06M0.89M0.04M0.46M0.08M0.74M0.09M
Net Shares Issued and RepurchasedNet Shares Issued
0.28M2.87M1.00M0.96M1.51M2.04M0.04M1.05M0.75M6.21M0.21M132.90M-0.06M0.89M0.04M0.46M0.08M0.74M0.09M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.28M2.87M1.00M0.96M1.51M2.04M0.04M1.05M0.75M6.21M0.21M132.90M-0.06M0.89M0.04M0.46M0.08M0.74M0.09M
Other financing activitiesOther financing
-6.41M-5.15M-8.60M-7.51M-9.18M-7.45M-8.96M-9.67M-9.91M-10.96M-11.75M-11.23M-9.53M-11.48M-7.61M-5.59M
Cash from Financing ActivitiesCash from Financing
-6.14M-2.28M-7.62M-6.83M-7.67M-5.42M-8.92M-9.04M-9.16M-4.81M-11.96M120.73M-9.45M-10.86M-7.74M-5.79M139.23M-7.08M-9.58M
Additional items
Change in Cash
-34.41M-28.69M117.52M-153.34M-70.50M-2.83M-21.59M-26.86M-1.27M-15.56M-18.75M78.45M-55.21M-1.15M0.91M72.58M-50.55M-20.76M-24.34M
Ending Cash Balance
258.40M229.72M347.24M193.90M123.40M120.57M98.98M72.12M70.86M55.30M36.55M115.01M59.80M58.65M59.56M132.13M81.59M60.83M36.50M38.52M
Free Cash FlowFCF
-55.91M-61.20M326.88M-66.88M-70.99M-55.51M-44.84M-85.74M-49.90M-50.85M-41.89M-56.01M-45.97M-40.88M-32.70M32.61M-49.73M-56.45M-52.80M
Net Cash FlowNCF
-34.41M-28.69M117.52M-153.34M-70.50M-2.83M-21.59M-26.86M-1.27M-15.56M-18.75M78.45M-55.21M-1.15M0.91M72.58M-50.55M-20.76M-24.34M
Interest Paid

Regenxbio Cash Flow Statement API

Pull Regenxbio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGNX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY